Anthem Biosciences Ltd. (ANTHEM): Anthem Biosciences Share Price hits fresh 52-week high on NSE

Anthem Biosciences Share Price was at Rs 955.25, up 0.60%, after touching a fresh 52-week high of Rs 970.80. The company’s market capitalisation stood at Rs 52,613.86 crore as of 04 September 2026 at 9:18 AM IST. The move places Anthem Biosciences Ltd. (ANTHEM) in focus in today’s stock news, with the latest Univest data confirming the price event but not establishing a company-specific catalyst.

The stock’s intraday range was Rs 952.50 to Rs 970.80, while the opening price was Rs 968.55 and the previous close was Rs 949.55. This means the share price briefly moved above the prior day’s reference and then traded lower than the morning peak, with turnover at Rs 0.61 crore. For readers tracking Anthem Biosciences Share Price Today, the event matters because it adds a fresh yearly high to the company’s stock news flow without requiring any assumption about why the move occurred.

Anthem Biosciences Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 955.25
Previous Close	Rs 949.55
Today's Move	+Rs 5.7 (+0.6%)
Open	Rs 968.55
High	Rs 970.8
Low	Rs 952.5
Turnover	Rs 0.61 crore
Market Capitalisation	Rs 52,613.86 crore

Anthem Biosciences Ltd. (ANTHEM) traded at Rs 955.25 versus the previous close of Rs 949.55, a rise of 0.6%. The stock opened at Rs 968.55, reached a high of Rs 970.8 and touched a low of Rs 952.5.

Anthem Biosciences Share Price Today reflects a day that opened above the previous close, reached a fresh 52-week high, and then traded below that peak as of the article timestamp. The stock opened at Rs 968.55 versus the previous close of Rs 949.55, and the day’s high matched the 52-week high at Rs 970.80. The day low was Rs 952.50, so the price stayed inside a relatively tight range around the session high for much of the early part of trade.

The stock was last traded at Rs 955.25, which is Rs 5.70 above the previous close. Turnover stood at Rs 0.61 crore. Since the current price is below the day’s high, the immediate story is not about a new intraday extreme beyond Rs 970.80; it is about the stock establishing a fresh yearly high and then trading near the upper part of the day’s band. That is the key price action behind today’s Anthem Biosciences Share Price move.

For readers scanning Anthem Biosciences Stock News or Anthem Biosciences Share News, the verified event is clear: a 52-week high was recorded during the session, and the share price remained elevated relative to the previous close. Univest tracks this kind of stock news because fresh highs often become the first search signal for a broader market update.

Anthem Biosciences Ltd. (ANTHEM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 52,613.86 crore
P/E Ratio	92.89x
P/B Ratio	17.1x
ROE	21.98%
ROCE	29.62%
EPS	Rs 10.22
Book Value Per Share	Rs 55.55
Dividend Yield	0.21%

Anthem Biosciences Ltd. (ANTHEM) fundamental metrics show P/E 92.89x, P/B 17.1x, ROE 21.98%, ROCE 29.62%. These figures provide context only and are not a buy or sell signal.

Anthem Biosciences Ltd. has a market capitalisation of Rs 52613.86 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 92.89x, P/B at 17.1x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.98% and ROCE of 29.62%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 10.22, book value per share of Rs 55.55, dividend yield of 0.21%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.28x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	92.89x
Benchmark Median P/E	32.28x
Benchmark Average P/E	48.57x
Benchmark P/E Range	3.32x to 645.91x
Company P/B Ratio	17.1x
Benchmark Median P/B	2.85x
Company ROE	21.98%
Benchmark Median ROE	11.78%
Company ROCE	29.62%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 52,613.86 crore
Benchmark Median Market Cap	Rs 723.58 crore

Anthem Biosciences Ltd. (ANTHEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 92.89x, which is above the benchmark median of 32.28x, a difference of +187.76%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Anthem Biosciences Ltd. (ANTHEM) has a ROE of 21.98%, which is above the benchmark median of 11.78%, a difference of +86.59%. Anthem Biosciences Ltd. (ANTHEM) has a ROCE of 29.62%, which is above the benchmark median of 13.65%, a difference of +117%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Abbott India Ltd.	ABBOTINDIA	55,301.63	34.06	10.62	34.67	46.72
Glaxosmithkline Pharmaceuticals Ltd.	GLAXO	49,917.18	46.55	19.73	48.76	66.79
Ipca Laboratories Ltd.	IPCALAB	49,633.42	37.87	5.85	15.88	19.41
Gland Pharma Ltd.	GLAND	47,265.42	42.45	4.51	10.56	14.96
Alkem Laboratories Ltd.	ALKEM	62,293.36	28.73	4.33	18.29	21.28

Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 92.89x compared with the displayed peer median of 37.87x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 21.98% compares with a peer median of 18.29% across the companies shown in the table. ROCE stood at 29.62% versus the displayed peer median of 21.28%, providing a capital-efficiency comparison. Anthem Biosciences Ltd. (ANTHEM) has a market capitalisation of Rs 52,613.86 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Anthem Biosciences

• Anthem Biosciences Share Price touched a fresh 52-week high of Rs 970.80 during the session.
• The stock last traded at Rs 955.25, above the previous close of Rs 949.55.
• Market capitalisation stood at Rs 52,613.86 crore.
• P/E was 92.89, P/B was 17.1, ROE was 21.98% and ROCE was 29.62%.
• The company operates in Healthcare and Pharmaceuticals & Drugs, with peer comparison available against other listed names.

About Anthem Biosciences

Anthem Biosciences Ltd. (ANTHEM) is classified in Healthcare and the Pharmaceuticals & Drugs industry. In this article, Anthem Biosciences Share Price is being tracked alongside company financials, market capitalisation and sector benchmarks. Univest uses this company profile to place the stock news event in the right industry context for readers searching Anthem Biosciences NSE, Anthem Biosciences BSE and Anthem Biosciences Stock News.

Frequently Asked Questions

Why did Anthem Biosciences Share Price touch a fresh 52-week high?

Ans. Anthem Biosciences Share Price touched Rs 970.80, a fresh 52-week high, and the latest Univest figures confirm the price event. The data does not establish a company-specific catalyst for the move.

What is Anthem Biosciences Share Price today?

Ans. Anthem Biosciences Share Price was Rs 955.25, up 0.60% from the previous close of Rs 949.55. The stock traded between Rs 952.50 and Rs 970.80 during the session.

What is the market capitalisation of Anthem Biosciences?

Ans. Anthem Biosciences had a market capitalisation of Rs 52,613.86 crore. That places Anthem Biosciences Share Price in a large company valuation bracket within the healthcare and pharmaceuticals space.

How does Anthem Biosciences look on valuation?

Ans. Anthem Biosciences Share Price is supported by a P/E of 92.89 and a P/B of 17.1. Those are above the same-industry medians of 32.28 and 2.85 respectively. The peer average P/E is 48.57x.

What do ROE and ROCE say about Anthem Biosciences?

Ans. Anthem Biosciences reported ROE of 21.98% and ROCE of 29.62%. Both ratios are above the same-industry medians, which gives investors a clearer operating-efficiency context for the share price.

What are EPS and book value for Anthem Biosciences?

Ans. EPS is Rs 10.22 and book value per share is Rs 55.55. For Anthem Biosciences Share Price, these figures help readers compare earnings per share and accounting net worth.

Does Anthem Biosciences pay a dividend?

Ans. Anthem Biosciences has a dividend yield of 0.21%. That is a historical yield measure and should be read alongside Anthem Biosciences Share Price, earnings metrics and broader valuation ratios.

How does Anthem Biosciences compare with peers?

Ans. Anthem Biosciences Share Price sits above several peers on market cap, while its P/E is higher than most supplied comparables. Its ROE and ROCE are also above several peer figures in the list.

Track Anthem Biosciences Share Price on Univest

Use Anthem Biosciences Ltd. (ANTHEM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

You can track Anthem Biosciences Share Price on Univest for live share price updates, company news, valuation ratios, market capitalisation, 52-week levels, sector context and peer comparison. Univest also helps readers follow Anthem Biosciences Share Price Today, Anthem Biosciences Latest News and Anthem Biosciences Stock Analysis in one place.